Connect with us

Health

Study finds wide variation in levels and anti-tumor effectiveness of a common cancer drug – News-Medical.Net

When used to manage infections, the drug itraconazole is generally given at a single, fixed dose to all patients.

Published

on

ADVERTISEMENT

Reviewed by Emily Henderson, B.Sc.Sep 17 2020
When used to manage infections, the drug itraconazole is generally given at a single, fixed dose to all patients. But determining the correct dosage of the drug to help treat cancer isn’t that simple, new research by UT Southwestern suggests.
When the team of researchers and clinicians measured how much itraconazole ended up in the bloodstreams and tumors of 13 patients treated for lung cancer, they found a sixfold variation in drug levels in tumor…

Click here to view the original article.

Health

NSW records no new community transmission for third consecutive day – 9News

New South Wales has recorded no new locally transmitted cases of COVID-19 in NSW for third day in row.

Published

on

ADVERTISEMENT

Auto News: Beat the price rises: currency pressure poised to push up the cost of cars in 2020 – caradvice.com.au

Click here to view the original article.

Continue Reading

Health

MS lifeline as drug that can slow disease listed – Chinchilla News

Patients who develop the second progressive stage of Multiple Sclerosis will only have to pay $41 for a drug that helps slow down the disease.

Published

on

post featured image
ADVERTISEMENT

Patients living with multiple sclerosis have been granted a lifeline with the federal government listing a drug that can help slow down the progression of the disease.
The move will mean all patients who might benefit from “Mayzent” will only have to pay $41 per script rather than the estimated $25,000 yearly cost.
Multiple sclerosis, known as MS, is the most commonly acquired neurological disease in younger adults with more than 25,600 Australians living with the condition.
The average age of diagnosis…

Click here to view the original article.

Continue Reading

Health

Rush for results could lead to inferior Covid vaccine, say scientists – The Guardian

Push to roll out injections may see elderly miss out on effective coronavirus inoculations

Published

on

ADVERTISEMENT

Scientists have warned that early adoption of a Covid vaccine with only moderate effectiveness could disrupt efforts to test and create improved versions. Immunising against the disease is not going to be a simple business of turning off the virus once the first vaccine appears, they say. In fact, there could be considerable confusion as researchers struggle to pinpoint the best versions for different vulnerable groups, such as the elderly.
The vaccines coming through fastest are the most experimental….

Click here to view the original article.

Continue Reading

Trending

You might also like ...

post featured image
Long COVID Syndrome: Study Points Risk Factors, Treatment and How to… – AlKhaleej Today
post featured image
The blood group influences the risk of infection – healing practice – AlKhaleej Today
post featured image
4 more COVID-19 deaths, 859 news cases – 55 of them… – AlKhaleej Today